Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and Design

Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4): A 26-week double-blind study

Diabetes Care ◽

10.2337/dc11-1107 ◽

2011 ◽

Vol 35 (2) ◽

pp. 252-258 ◽

Cited By ~ 210

Author(s):

D. Russell-Jones ◽

R. M. Cuddihy ◽

M. Hanefeld ◽

A. Kumar ◽

J. G. Gonzalez ◽

...

Keyword(s):

Type 2 Diabetes ◽

Diabetes Duration ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Double Blind ◽

Drug Naïve

Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea-metformin therapy: a randomized, double-blind study (T-emerge 6)

10.1111/dom.12009 ◽

2012 ◽

Vol 15 (3) ◽

pp. 234-240 ◽

Cited By ~ 15

Author(s):

R. E. Pratley ◽

D. Urosevic ◽

M. Boldrin ◽

R. Balena ◽

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Metformin Therapy

The effects of LY2189265, a long-acting glucagon-like peptide-1 analogue, in a randomized, placebo-controlled, double-blind study of overweight/obese patients with type 2 diabetes: the EGO study

10.1111/j.1463-1326.2011.01366.x ◽

2011 ◽

Vol 13 (5) ◽

pp. 418-425 ◽

Cited By ~ 63

Author(s):

G. E. Umpierrez ◽

T. Blevins ◽

J. Rosenstock ◽

C. Cheng ◽

J. H. Anderson ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Obese Patients ◽

Double Blind ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Long Acting

Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study

10.1111/j.1463-1326.2011.01545.x ◽

2012 ◽

Vol 14 (4) ◽

pp. 348-357 ◽

Cited By ~ 77

Author(s):

R. Kawamori ◽

N. Inagaki ◽

E. Araki ◽

H. Watada ◽

N. Hayashi ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Japanese Patients ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Active Comparator ◽

Control Versus

Optimizing Insulin Secretagogue Therapy in Patients With Type 2 Diabetes: A randomized double-blind study with repaglinide

Diabetes Care ◽

10.2337/diacare.25.2.342 ◽

2002 ◽

Vol 25 (2) ◽

pp. 342-346 ◽

Cited By ~ 31

Author(s):

O. Schmitz ◽

S. Lund ◽

P. H. Andersen ◽

M. Jonler ◽

N. Porksen

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Double Blind ◽

Insulin Secretagogue

Effects ofα-Lipoic Acid, Carnosine, and Thiamine Supplementation in Obese Patients with Type 2 Diabetes Mellitus: A Randomized, Double-Blind Study

Journal of Medicinal Food ◽

10.1089/jmf.2018.0007 ◽

2018 ◽

Vol 21 (12) ◽

pp. 1197-1203 ◽

Cited By ~ 12

Author(s):

Spyridon Karkabounas ◽

Nikolaos Papadopoulos ◽

Chryssa Anastasiadou ◽

Chrysoula Gubili ◽

Dimitrios Peschos ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Lipoic Acid ◽

Blind Study ◽

Double Blind Study ◽

Obese Patients ◽

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a multi-centre, randomized, placebo-controlled, double-blind study

10.1111/dom.12745 ◽

2016 ◽

Vol 18 (12) ◽

pp. 1207-1216 ◽

Cited By ~ 29

Author(s):

Hisamitsu Ishihara ◽

Susumu Yamaguchi ◽

Ikko Nakao ◽

Akira Okitsu ◽

Seitaro Asahina

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Japanese Patients ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study: Table 1

Diabetes Care ◽

10.2337/dc14-1038 ◽

2014 ◽

Vol 37 (11) ◽

pp. 3121-3123 ◽

Cited By ~ 5

Author(s):

Richard W. Simpson ◽

Geoffrey C. Nicholson ◽

Joseph Proietto ◽

Alana Sarah ◽

Kerrie M. Sanders ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study)

10.1111/dom.14061 ◽

2020 ◽

Vol 22 (9) ◽

pp. 1527-1536

Author(s):

Gyuri Kim ◽

Soo Lim ◽

Hyuk‐Sang Kwon ◽

Ie B. Park ◽

Kyu J. Ahn ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blind Study ◽

Double Blind Study ◽

Efficacy And Safety ◽

Open Label ◽

Double Blind ◽

Open Label Extension

Glulisine Versus Human Regular Insulin in Combination With Glargine in Noncritically Ill Hospitalized Patients With Type 2 Diabetes: A randomized double-blind study

Diabetes Care ◽

10.2337/dc10-0957 ◽

2010 ◽

Vol 33 (12) ◽

pp. 2496-2501 ◽

Cited By ~ 19

Author(s):

C. Meyer ◽

A. Boron ◽

E. Plummer ◽

M. Voltchenok ◽

R. Vedda

Keyword(s):

Type 2 Diabetes ◽

Regular Insulin ◽

Hospitalized Patients ◽

Blind Study ◽

Double Blind Study ◽